tiprankstipranks
Trending News
More News >
Moleculin Biotech (MBRX)
NASDAQ:MBRX
US Market

Moleculin Biotech (MBRX) Income Statement

Compare
1,907 Followers

Moleculin Biotech Income Statement

Last quarter (Q3 2025), Moleculin Biotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Moleculin Biotech's net income was $-25.40M. See Moleculin Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 26.64M$ 29.63M$ 30.64M$ 22.97M$ 19.74M
Depreciation and Amortization
$ 126.00K$ 127.00K$ 130.00K$ 164.00K$ 200.00K
EBITDA
$ -26.52M$ -29.50M$ -30.51M$ -22.80M$ -19.54M
Operating Income
$ -26.64M$ -29.63M$ -30.64M$ -22.97M$ -19.74M
Other Income/Expenses
$ 4.88M$ -138.00K$ 1.61M$ 7.07M$ 2.39M
Pretax Income
$ -21.76M$ -29.77M$ -29.02M$ -15.89M$ -17.36M
Net Income
$ -21.76M$ -29.77M$ -29.02M$ -15.89M$ -17.36M
Per Share Metrics
Basic EPS
$ -158.00$ -376.75$ -380.50$ -221.75$ -661.00
Diluted EPS
$ -158.00$ -376.75$ -380.50$ -221.75$ -661.00
Weighted Average Shares Outstanding
137.72K 79.02K 76.28K 71.67K 26.25K
Weighted Average Shares Outstanding (Diluted)
137.72K 79.02K 76.28K 71.67K 26.25K
Currency in USD

Moleculin Biotech Earnings and Revenue History